Atlas Trials

MGTA-145 + Plerixafor in the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma

Clinical trial NCT04552743 · COMPLETED

Trial details

NCT number
NCT04552743
Sponsor
Surbhi Sidana, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2020-10-05
Primary completion
2021-07-22
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.